These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 11151062

  • 1. Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes.
    Friedline JA, Ahmad E, Garcia D, Blue D, Ceniza N, Mattson JC, Crisan D.
    Arch Pathol Lab Med; 2001 Jan; 125(1):105-11. PubMed ID: 11151062
    [Abstract] [Full Text] [Related]

  • 2. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.
    Federici EH, Al-Mondhiry H.
    Thromb Res; 2019 Oct; 182():75-78. PubMed ID: 31472339
    [Abstract] [Full Text] [Related]

  • 3. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A, Mosena L, Prins MH, Prandoni P.
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [Abstract] [Full Text] [Related]

  • 4. Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
    Saemundsson Y, Sveinsdottir SV, Svantesson H, Svensson PJ.
    J Thromb Thrombolysis; 2013 Oct; 36(3):324-31. PubMed ID: 23054468
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
    Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.
    N Engl J Med; 1999 Sep 09; 341(11):801-6. PubMed ID: 10477778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N.
    J Natl Cancer Inst; 2006 Jul 05; 98(13):904-10. PubMed ID: 16818854
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism.
    Caiano L, Kovacs MJ, Lazo-Langner A, Anderson DR, Kahn SR, Shah V, Kaatz S, Zide RS, Schulman S, Chagnon I, Mallick R, Rodger MA, Wells PS.
    J Thromb Haemost; 2023 Mar 05; 21(3):553-558. PubMed ID: 36710196
    [Abstract] [Full Text] [Related]

  • 16. Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene "Mutation" (G20210A).
    Favaloro EJ.
    Semin Thromb Hemost; 2019 Oct 05; 45(7):730-742. PubMed ID: 31398733
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.